Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets

被引:2
|
作者
Nisar, Ayesha [1 ,2 ,3 ]
Khan, Sawar [4 ,5 ]
Li, Wen [6 ]
Hu, Li [1 ,2 ,3 ]
Samarawickrama, Priyadarshani Nadeeshika [1 ,2 ,3 ]
Gold, Naheemat Modupeola [1 ,2 ,3 ]
Zi, Meiting [1 ,3 ]
Mehmood, Sardar Azhar [7 ]
Miao, Jiarong [8 ]
He, Yonghan [1 ,2 ,3 ]
机构
[1] Chinese Acad Sci, Kunming Inst Zool, Key Lab Genet Evolut & Anim Models, KIZ CUHK Joint Lab Bioresources & Mol Res Common D, Kunming, Yunnan, Peoples R China
[2] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Peoples R China
[3] Chinese Acad Sci, Kunming Inst Zool, Key Lab Hlth Aging Res Yunnan Prov, Kunming, Yunnan, Peoples R China
[4] Cent South Univ, Sch Life Sci, Dept Cell Biol, Changsha, Hunan, Peoples R China
[5] Univ Lahore, Inst Mol Biol & Biotechnol, Lahore, Pakistan
[6] Dali Univ, Affiliated Hosp 2, Peoples Hosp Yunnan Prov 3, Dept Endocrinol, Kunming, Yunnan, Peoples R China
[7] Hazara Univ, Dept Zool, Mansehra, Pakistan
[8] Kunming Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Kunming, Yunnan, Peoples R China
来源
MEDCOMM | 2024年 / 5卷 / 11期
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
age-related disease; aging; hypoxia; mechanism; therapeutic target; NF-KAPPA-B; CHRONIC INTERMITTENT HYPOXIA; INDUCED TAU PHOSPHORYLATION; ALTITUDE CEREBRAL EDEMA; OBSTRUCTIVE SLEEP-APNEA; SENESCENT CELLS; CELLULAR SENESCENCE; ALZHEIMERS-DISEASE; INDUCIBLE FACTORS; STEM-CELLS;
D O I
10.1002/mco2.786
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aging is a complex biological process characterized by the gradual decline of cellular functions, increased susceptibility to diseases, and impaired stress responses. Hypoxia, defined as reduced oxygen availability, is a critical factor that influences aging through molecular pathways involving hypoxia-inducible factors (HIFs), oxidative stress, inflammation, and epigenetic modifications. This review explores the interconnected roles of hypoxia in aging, highlighting how hypoxic conditions exacerbate cellular damage, promote senescence, and contribute to age-related pathologies, including cardiovascular diseases, neurodegenerative disorders, cancer, metabolic dysfunctions, and pulmonary conditions. By examining the molecular mechanisms linking hypoxia to aging, we identify key pathways that serve as potential therapeutic targets. Emerging interventions such as HIF modulators, antioxidants, senolytics, and lifestyle modifications hold promise in mitigating the adverse effects of hypoxia on aging tissues. However, challenges such as the heterogeneity of aging, lack of reliable biomarkers, and safety concerns regarding hypoxia-targeted therapies remain. This review emphasizes the need for personalized approaches and advanced technologies to develop effective antiaging interventions. By integrating current knowledge, this review provides a comprehensive framework that underscores the importance of targeting hypoxia-induced pathways to enhance healthy aging and reduce the burden of age-related diseases. Aging involves the decline of cellular functions and increased disease susceptibility. Hypoxia, or reduced oxygen availability, accelerates aging by influencing pathways like hypoxia-inducible factors (HIFs), oxidative stress, and inflammation. This review highlights how hypoxia exacerbates cellular damage, promotes senescence, and contributes to age-related diseases. Emerging therapies, such as HIF modulators and senolytics, show promise in mitigating hypoxia's impact on aging. image
引用
收藏
页数:27
相关论文
共 50 条
  • [31] Obesity and aging: Molecular mechanisms and therapeutic approaches
    Santos, Ana L.
    Sinha, Sanchari
    AGEING RESEARCH REVIEWS, 2021, 67
  • [32] Hypoxia-inducible factors as molecular targets for liver diseases
    Cynthia Ju
    Sean P. Colgan
    Holger K. Eltzschig
    Journal of Molecular Medicine, 2016, 94 : 613 - 627
  • [33] Hypoxia-inducible factors as molecular targets for liver diseases
    Ju, Cynthia
    Colgan, Sean P.
    Eltzschig, Holger K.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2016, 94 (06): : 613 - 627
  • [34] Therapeutic Potential and Molecular Targets of Piceatannol in Chronic Diseases
    Surh, Young-Joon
    Na, Hye-Kyung
    ANTI-INFLAMMATORY NUTRACEUTICALS AND CHRONIC DISEASES, 2016, 928 : 185 - 211
  • [35] Retinal ischemic diseases and promising therapeutic molecular targets
    Lee, Deokho
    Tomita, Yohei
    Negishi, Kazuno
    Kurihara, Toshihide
    HISTOLOGY AND HISTOPATHOLOGY, 2025, 40 (01) : 11 - 20
  • [36] Molecular mechanisms and therapeutic strategies for prion diseases
    Katamine, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 8P - 8P
  • [37] Molecular mechanisms and therapeutic strategies for neuromuscular diseases
    Andrea, Zambon Alberto
    Matteo, Falzone Yuri
    Alessandra, Bolino
    Carlo, Previtali Stefano
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
  • [38] Molecular mechanisms and therapeutic target of NETosis in diseases
    Huang, Jiayu
    Hong, Weiqi
    Wan, Meihua
    Zheng, Limin
    MEDCOMM, 2022, 3 (03):
  • [39] New Insights for Cellular and Molecular Mechanisms of Aging and Aging-Related Diseases: Herbal Medicine as Potential Therapeutic Approach
    Liu, Yanfei
    Weng, Weiliang
    Gao, Rui
    Liu, Yue
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 2019
  • [40] Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?
    Avci, Edibe
    Sarvari, Pouya
    Savai, Rajkumar
    Seeger, Werner
    Pullamsetti, Soni S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)